<?xml version="1.0" encoding="UTF-8"?>
<mods xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.loc.gov/mods/v3" version="3.1" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-1.xsd">
  <titleInfo>
    <title>Litt's drug eruption &amp; reaction manual</title>
  </titleInfo>
  <name type="personal">
    <namePart>Neil H. Shear</namePart>
    <role>
      <roleTerm authority="marcrelator" type="text">creator</roleTerm>
    </role>
  </name>
  <typeOfResource>text</typeOfResource>
  <originInfo>
    <place>
      <placeTerm type="text">Boca Raton</placeTerm>
    </place>
    <publisher>CRC Press</publisher>
    <dateIssued>2022</dateIssued>
    <issuance>monographic</issuance>
  </originInfo>
  <language>
    <languageTerm authority="iso639-2b" type="code">eng</languageTerm>
  </language>
  <physicalDescription>
    <form authority="marcform">print</form>
  </physicalDescription>
  <tableOfContents>Drug profiles: generic names A-Z --- Descriptions of important reactions Drugs that cause important reactions --- lnvestigational drugs for the treatment of COVID-19 --- Main classes of drugs --- Class reactions --- ACE inhibitors --- Antiarrhythmics --- Antibiotics, imidazole --- Antibiotics, macrolide --- Anticonvulsants --- Antidepressants, tricyclic --- Antihistamines (H I) --- Antimalarials --- Antipsychotics --- Antiretrovirals --- Benzodiazepines --- Beta blockers --- Biologics, immune checkpoint inhibitors --- Biologics, monoclonal antibodies --- Bisphosphonates --- Calcium channel blockers --- Cephalosporins --- Corticosteroids, topical --- Disease-modifying antirheumatic drugs (DMARDS) --- DPP-4 inhibitors --- Epidermal growth factor receptor (EGFR) inhibitors --- Fluoroquinolones --- Non-steroidal anti-inflammatory drugs (NSAIDS) --- Proton pump inhibitors (PPI) --- Statins --- TNF inhibitors --- Tyrosine-kinase inhibitors --- Genetic tables --- Concordance of synonyms and trade names with generic names</tableOfContents>
  <subject>
    <topic>Dermatotoxicology</topic>
  </subject>
  <subject>
    <topic>Drug Eruptions</topic>
  </subject>
  <subject>
    <topic>Drug-exanthems</topic>
  </subject>
  <subject>
    <topic>Drugs Side effects</topic>
  </subject>
  <classification authority="nlm">WR39 S583 2022</classification>
  <recordInfo>
    <recordContentSource authority="marcorg">TH-BaNU</recordContentSource>
    <recordCreationDate encoding="marc">220917</recordCreationDate>
    <recordChangeDate encoding="iso8601">20220917115458.0</recordChangeDate>
  </recordInfo>
</mods>
